Showcasing Southern California's innovation, one startup at a time. Every funded and bootstrapped company, from seed round to first dollar of revenue, tracked as it happens.
Includes SEC Form D filings from the last 3 years, plus all-time totals for companies sourced from YC and news coverage.

The region's largest single cluster by company count — AI and machine learning threaded through nearly every other industry here, from defense to biotech to entertainment.

Home to SpaceX, Northrop Grumman, and a new wave of hypersonics and space-infrastructure startups.

Hollywood's production infrastructure, live events, and a growing games and creator-tools scene.

Qualcomm and Broadcom anchor a chip-design cluster spanning the region.

A deep biotech research base and a growing bench of medical device and diagnostics startups.

Business software and services sold to other companies. The largest single category of startup across Southern California, spanning sales tools, vertical operating systems, and everything in between.

Manufacturing, hardware, and physical-world operations. Overlaps heavily with the region's decades-old aerospace and defense manufacturing base, now extending into robotics and automated production.

Products and apps built directly for individual consumers, drawing on Southern California's media and entertainment base.

Health tech, medical devices, and healthcare services, backed by a decades-old biotech research base and a deep bench of clinical and diagnostics startups.

Financial technology: payments, banking, investing, and financial infrastructure.

Education technology and learning platforms built across Southern California.

Property technology, construction tech, and real estate services.
This LA-based entity does business as HexClad, the hybrid cookware brand known for its celebrity partnership with chef Gordon Ramsay.

DigitalBridge is a leading global alternative asset manager dedicated to investing in next-generation digital infrastructure and GenerativeAI

We at Boundless Bio are pioneers in understanding and treating the most intractable cancers. We have charted a new spatial map of the cancer genome within cancer cells and are harnessing our scientific founders’ discoveries about “extrachromosomal DNA,” or ecDNA, to drive a revolution in cancer therapeutics.
Mobix Labs went public on the Nasdaq (MOBX) in December 2023 via a SPAC merger with Chavant Capital Acquisition Corp.
Navitas, co-founded and led by CEO Gene Sheridan, went public in October 2021 via a SPAC merger with Live Oak Acquisition Corp II.

No math. No dosing decisions. Just freedom to live.
Enlaza Therapeutics is pioneering the field of covalent biologics, developing a novel classes of protein therapeutics based on its proprietary War-Lock™ platform.